Additionally, cytotoxicity assays against ESCC cell lines demonstrated that HMGB2 overexpression significantly impaired NK cell-mediated tumor cell killing, with reduced tumor cell lysis observed at multiple effector-to-target ratios (Figure 5e). Here, HMGB2 is linked to neoplasm.